Quick filters
- Amgen?s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion PR Newswire | Wednesday April 20, 2011 4:01PM
- Amgen to Webcast 2011 Business Review Meeting on April 21 PR Newswire | Thursday April 14, 2011 4:32PM
- Amgen Announces Webcast of 2011 First Quarter Financial Results PR Newswire | Wednesday April 13, 2011 4:36PM
- Amgen Establishes Commercial Operations in Brazil PR Newswire | Friday April 8, 2011 8:56AM
- Amgen to Appeal CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer in Europe PR Newswire | Wednesday March 30, 2011 4:05PM
- Top-Line Results Announced of Pivotal Phase 3 Motesanib Trial in Advanced Non-Squamous Non-Small Cell Lung Cancer Patients PR Newswire | Wednesday March 30, 2011 7:05AM
- Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial PR Newswire | Wednesday March 23, 2011 4:06PM
- Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate PR Newswire | Wednesday March 23, 2011 4:05PM
- ITG's Majestic Market Research Prostate Cancer Study Indicates Amgen's Xgeva is Poised to Steal Significant Share From Novartis' Zometa; Physicians Still on the Fence About Dendreon's Provenge PR Newswire | Tuesday March 22, 2011 4:15PM
- Amgen Statement on CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer PR Newswire | Friday March 18, 2011 8:06AM
- Amgen Donates $1 Million to Help Japanese Disaster Victims PR Newswire | Monday March 14, 2011 5:54PM
- Amgen Completes Acquisition of BioVex PR Newswire | Friday March 4, 2011 4:16PM
- Amgen to Present at the Cowen and Company 31st Annual Healthcare Conference PR Newswire | Thursday March 3, 2011 4:08PM
- Breakaway From Cancer® Launches Newly-Enhanced Website Offering Comprehensive, Tailored Support for Cancer Patients PR Newswire | Thursday March 3, 2011 9:00AM
- World-Class Professional Golfer Phil Mickelson Launches 'On Course with Phil' for People with Certain Inflammatory Joint and Skin Conditions PR Newswire | Wednesday March 2, 2011 8:30AM
- NBPTS and Amgen Foundation Join to Bolster Science Education PR Newswire | Tuesday March 1, 2011 4:33PM
- Results Published in The Lancet Demonstrate Superiority of XGEVA? (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer PR Newswire | Thursday February 24, 2011 7:05PM
- Amgen to Present at the Citi 2011 Global Healthcare Conference PR Newswire | Thursday February 24, 2011 5:54PM
- The Journal of Clinical Oncology Publishes Phase 3 XGEVA? (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma PR Newswire | Tuesday February 22, 2011 4:05PM
- Enbrel® (etanercept) Significantly Improved Scalp Involvement in Patients with Moderate to Severe Plaque Psoriasis PR Newswire | Friday February 4, 2011 9:00AM
Live Discussion of AMGN on StockTwits